Literature DB >> 17721809

Ubiquitylation of epsilon-COP by PIRH2 and regulation of the secretion of PSA.

Satoru Maruyama1, Naoto Miyajima, Miyuki Bohgaki, Tadasuke Tsukiyama, Masahiko Shigemura, Katsuya Nonomura, Shigetsugu Hatakeyama.   

Abstract

Ubiquitylation appears to be involved in the membrane trafficking system including endocytosis, exocytosis, and ER-to-Golgi transport. We found that PIRH2, which was identified as an interacting protein for androgen receptor or p53, interacts with and ubiquitylates the epsilon-subunit of coatmer complex, epsilon-COP. PIRH2 promotes the ubiquitylation of epsilon-COP in vitro and in vivo and consequently promotes the degradation of epsilon-COP. The interaction between PIRH2 and epsilon-COP is affected by the presence of androgen, and PIRH2 in the presence of androgen promotes ubiquitylation of epsilon-COP in vivo. Furthermore, overexpression of the wild type of PIRH2 in prostate cancer cells causes downregulation of the secretion of prostate-specific antigen (PSA), a secretory protein in prostate epithelial cells and one of diagnostic markers for prostate cancer. Our results indicate that PIRH2 functions as a regulator for COP I complex.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17721809     DOI: 10.1007/s11010-007-9586-3

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  39 in total

1.  Expression of androgen receptor coregulatory proteins in prostate cancer and stromal-cell culture models.

Authors:  C Nessler-Menardi; I Jotova; Z Culig; I E Eder; T Putz; G Bartsch; H Klocker
Journal:  Prostate       Date:  2000-10-01       Impact factor: 4.104

2.  U box proteins as a new family of ubiquitin-protein ligases.

Authors:  S Hatakeyama; M Yada; M Matsumoto; N Ishida; K I Nakayama
Journal:  J Biol Chem       Date:  2001-07-02       Impact factor: 5.157

Review 3.  The ubiquitin system.

Authors:  A Hershko; A Ciechanover
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 4.  Mechanisms of intracellular protein transport.

Authors:  J E Rothman
Journal:  Nature       Date:  1994-11-03       Impact factor: 49.962

5.  Different expression of androgen receptor coactivators in human prostate.

Authors:  N Fujimoto; A Mizokami; S Harada; T Matsumoto
Journal:  Urology       Date:  2001-08       Impact factor: 2.649

6.  Antipeptide antibodies to two distinct regions of the androgen receptor localize the receptor protein to the nuclei of target cells in the rat and human prostate.

Authors:  D A Husmann; C M Wilson; M J McPhaul; W D Tilley; J D Wilson
Journal:  Endocrinology       Date:  1990-05       Impact factor: 4.736

Review 7.  Androgen receptor involvement in the progression of prostate cancer.

Authors:  H Suzuki; T Ueda; T Ichikawa; H Ito
Journal:  Endocr Relat Cancer       Date:  2003-06       Impact factor: 5.678

8.  Identification and characterization of a ligand-regulated nuclear export signal in androgen receptor.

Authors:  Anthony J Saporita; Qiuheng Zhang; Neema Navai; Zehra Dincer; Junghyun Hahn; Xiaoyan Cai; Zhou Wang
Journal:  J Biol Chem       Date:  2003-08-15       Impact factor: 5.157

9.  Prostate specific antigen and gleason grade: an immunohistochemical study of prostate cancer.

Authors:  M Aihara; R M Lebovitz; T M Wheeler; B M Kinner; M Ohori; P T Scardino
Journal:  J Urol       Date:  1994-06       Impact factor: 7.450

10.  Sorting of Golgi resident proteins into different subpopulations of COPI vesicles: a role for ArfGAP1.

Authors:  J Lanoix; J Ouwendijk; A Stark; E Szafer; D Cassel; K Dejgaard; M Weiss; T Nilsson
Journal:  J Cell Biol       Date:  2001-12-17       Impact factor: 10.539

View more
  5 in total

1.  The p73 tumor suppressor is targeted by Pirh2 RING finger E3 ubiquitin ligase for the proteasome-dependent degradation.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

Review 2.  Pirh2 RING-finger E3 ubiquitin ligase: its role in tumorigenesis and cancer therapy.

Authors:  Yong-Sam Jung; Yingjuan Qian; Xinbin Chen
Journal:  FEBS Lett       Date:  2012-04-03       Impact factor: 4.124

3.  The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover.

Authors:  M Bohgaki; A Hakem; M J Halaby; T Bohgaki; Q Li; P A Bissey; J Shloush; T Kislinger; O Sanchez; Y Sheng; R Hakem
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

Review 4.  Post-Translational Modifications That Drive Prostate Cancer Progression.

Authors:  Ivana Samaržija
Journal:  Biomolecules       Date:  2021-02-09

Review 5.  Directing Traffic: Regulation of COPI Transport by Post-translational Modifications.

Authors:  Peter M Luo; Michael Boyce
Journal:  Front Cell Dev Biol       Date:  2019-09-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.